New Drugs and Novel Mechanisms of Action in Treating Patients With Multiple Myeloma

November 4, 2016

Learning Objectives

  • Differentiate between the various mechanisms of action of new and emerging agents used to treat multiple myeloma.
  • List monitoring parameters for toxicities associated with newer agents used to treat multiple myeloma.
  • Describe the signs of early and serious toxicity that providers and patients need to be aware of when initiating therapy with new agents for multiple myeloma.
  • Identify the optimal drug therapy regimen for individual patients with multiple myeloma on patient-specific factors.
Course summary
Available credit: 
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 ANCC
Course opens: 
11/04/2016
Course expires: 
06/08/2017
Event starts: 
11/04/2016 - 4:25pm
Event ends: 
11/04/2016 - 5:25pm
Cost:
$0.00
Rating: 
0
Gaylord National Hotel
National Harbor, MD
United States

Available Credit

  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 ANCC

Price

Cost:
$0.00
Please login or register to take this course.